Walleye Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-360
| Closed | -$22K | – | 1906 |
|
|
2019
Q4 | $22K | Sell |
360
-2,952
| -89% | -$180K | ﹤0.01% | 1186 |
|
|
2019
Q3 | $187K | Sell |
3,312
-2,997
| -48% | -$169K | ﹤0.01% | 749 |
|
|
2019
Q2 | $351K | Sell |
6,309
-224
| -3% | -$12.5K | ﹤0.01% | 556 |
|
|
2019
Q1 | $330K | Buy |
6,533
+5,629
| +623% | +$284K | ﹤0.01% | 533 |
|
|
2018
Q4 | $36K | Sell |
904
-5,345
| -86% | -$213K | ﹤0.01% | 1257 |
|
|
2018
Q3 | $433K | Buy |
6,249
+3,534
| +130% | +$245K | ﹤0.01% | 815 |
|
|
2018
Q2 | $205K | Buy |
+2,715
| New | +$205K | ﹤0.01% | 987 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1835 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1770 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1819 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 2140 |
|
|
2017
Q1 | – | Sell |
-700
| Closed | -$56K | – | 2357 |
|
|
2016
Q4 | $56K | Sell |
700
-3,741
| -84% | -$299K | ﹤0.01% | 1087 |
|
|
2016
Q3 | $311K | Buy |
4,441
+3,479
| +362% | +$244K | ﹤0.01% | 602 |
|
|
2016
Q2 | $37K | Buy |
+962
| New | +$37K | ﹤0.01% | 1176 |
|
|
2015
Q4 | – | Sell |
-400
| Closed | -$30K | – | 2657 |
|
|
2015
Q3 | $30K | Buy |
400
+300
| +300% | +$22.5K | ﹤0.01% | 1142 |
|
|
2015
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 1343 |
|